₹103 per tablet of 200 mg during its launch, and an entire two-week course of treatment required 122 tablets, leading to a total cost of ₹12,500.
It had, however, last week, slashed the price by 27% to ₹75 per pill, or ₹9,150 for the course.Somani, who heads the country’s apex regulatory body Central Drugs Standards Control Organisation (CDSCO), has asked the company to provide a clarification on the matter.